Grant: Building the Foundation of the JPIAMR VRI
University of British Columbia
$75,000.00
AMRIC - Antimicrobial Resistance in Intensive Care
EF 2018-19
Résumé
InFACT - the International Forum for Acute Care Trialists - is an established
platform to promote international collaboration in acute care research. The
AMRIC (Antimicrobial Resistance in Intensive Care) proposal will use the InFACT
infrastructure and collaboration network to spearhead a global acute care
initiative for research on antimicrobial resistance.
InFACT was established by independent investigator-led clinical research groups
and academic research consortia to provide a mechanism to build international
collaboration, to address common needs, and to raise the profile of investigator drivenacute care research with researchers, policymakers, funders and the
general public. Currently, there are 35 member networks. These represent every
continent and income-grouping on the planet and share a common goal of
advancing science and building research capacity. InFACT member networks are the leading research networks in critical care, with embedded mentoring and
knowledge exchange activities.
AMRIC, using the InFACT model and its pre-existing collaborations, will scale-up
a plan for data sharing on the sources, burden, modifiable risk factors, and
impact of antimicrobial resistance in acute care settings around the world.
Through a recently funded and established mapping platform (ACCESS-MAPS,
co-investigator Wallace) and a large team of motivated investigators, we will
implement a plan for clinical and microbiologic data sharing for determining the
scale of the problem in acute care settings globally. We have recently conducted
scoping reviews on the subject through prior JPIAMR support; this proposal will
allow for building plans for implementation of the findings and coordinating the
scaling-up of prospective data collection.
Programme
Building the Foundation of the JPIAMR VRI
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
387460
Name
University of British Columbia .
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Partnername
Academy of Scientific Research & Technology (Cairo, Egypt); German Federal Ministry of Research, Technology and Space (Berlin); Instituto de Salud Carloss III (Spain); Medical Research Council (UK); The French National Research Agency (France); The Netherlands Organization for Health Research and Development (ZonMw); The Research Council of Norway; Ministero della Salute (Italy); Swedish Research Council (Sweden)
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Special Cases
Projecttitle
AMRIC - Antimicrobial Resistance in Intensive Care
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$75,000
Cihrequipment2
$0
Programname2
Building the Foundation of the JPIAMR VRI
Keyworddelim
Antimicrobial Resistance; Global Health; Intensive Care
Abstract
InFACT - the International Forum for Acute Care Trialists - is an established
platform to promote international collaboration in acute care research. The
AMRIC (Antimicrobial Resistance in Intensive Care) proposal will use the InFACT
infrastructure and collaboration network to spearhead a global acute care
initiative for research on antimicrobial resistance.
InFACT was established by independent investigator-led clinical research groups
and academic research consortia to provide a mechanism to build international
collaboration, to address common needs, and to raise the profile of investigator drivenacute care research with researchers, policymakers, funders and the
general public. Currently, there are 35 member networks. These represent every
continent and income-grouping on the planet and share a common goal of
advancing science and building research capacity. InFACT member networks are the leading research networks in critical care, with embedded mentoring and
knowledge exchange activities.
AMRIC, using the InFACT model and its pre-existing collaborations, will scale-up
a plan for data sharing on the sources, burden, modifiable risk factors, and
impact of antimicrobial resistance in acute care settings around the world.
Through a recently funded and established mapping platform (ACCESS-MAPS,
co-investigator Wallace) and a large team of motivated investigators, we will
implement a plan for clinical and microbiologic data sharing for determining the
scale of the problem in acute care settings globally. We have recently conducted
scoping reviews on the subject through prior JPIAMR support; this proposal will
allow for building plans for implementation of the findings and coordinating the
scaling-up of prospective data collection.
Competitiondate
201807
Approvedterm2
1 yr 0 mth
Pinamesdelim
University of British Columbia, .; Murthy, Srinivas
Approvedterm
1 an 0 mois
Cihrcontribution2
Antimicrobial Resistance~ $75,000~ $0~